I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Anxiety, defined as a state of apprehension and physical tension combined with activation of the autonomous nervous system, is a common emotional reaction to fear experienced by the patients before dental treatments or the application of local anesthetic. This emotional status is accompanied by a neuroendocrine response with hemodynamic disturbances and metabolic effects, which has been related to\[[@ref1]\] the reduction of pain tolerance threshold,\[[@ref2]\] an increase in the possibility that nonharmful stimulants may be interpreted as painful, and\[[@ref3]\] occurrence of complications such as tachycardia, fluctuations in arterial pressure, or vasovagal responses. Control of anxiety before and during dental appointments is important to ensure safety of the procedure to promote overall patient and surgeon satisfaction. With that objective psychologic or pharmacologic techniques are frequently used in the dental office especially in patients undergoing oral surgery including dental implants. One of those technique is the use of sedation, which has emerged as a popular technique in the literature.\[[@ref1]\] The use of benzodiazepines such as diazepam and midazolam has drawn a major development to avoid general anesthesia. In minor oral surgical procedures, Conscious sedation can be considered as a better option as it a simple procedure, it takes less time and can also be used on patients who are medically compromised. With patients who are likely to be less compliant because of fear of local anesthetic injections and anxiety toward surgical procedures under local anesthesia, conscious sedation can be useful. Midazolam is one of the available drugs for conscious sedation, commonly administered intravenously and also available as a nasal spray. Keeping all the aforementioned parameters in view, this study was carried out to compare conscious sedation with midazolam through intranasal spray and conventional intravenous (IV) routes.

P[ATIENTS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
================================================

A total of 60 patients were selected. Inclusion criteria for conscious sedations are patients between 10 and 50 years of age; patients who are ready for periodic review; patients having more stress, fear, and anxiety; patients who were uncooperative for surgery; and patients under American society of anesthesiologists grade I and II. Patients with a history of serious psychiatric illness, chronic use of central nervous system depressants or antidepressants, or alcohol abuse; morbidly obese patients (body mass index more than 30), who reported a history of anesthetic-related complications; and patients who were pregnant were excluded. The selected patients were randomly divided into two groups: In group A (test group), 30 patients in whom midazolam nasal spray (0.1 mg/kg; Insed Atomizer) was used, with each metered dose of 100 µL of Insed Atomizer delivers 0.5 mg midazolam, and in Group A patient with periapical cyst had enucleation done using intranasal midazolam spray. Patient had no pain throughout the procedure \[Figures [1](#F1){ref-type="fig"}--[6](#F6){ref-type="fig"}\]. Group B patient with symphysis fracture had reduction done using IV midazolam and proper occlusion was attained \[Figures [7](#F7){ref-type="fig"}--[13](#F13){ref-type="fig"}\]. Group B (control group), 30 patients in whom conventional IV midazolam (0.1 mg/kg) was used. Physiological parameters, anxiety score, sedation rating, patient's cooperation score, and retrograde and anterograde amnesia were recorded for each patient during preoperative, intraoperative, and postoperative period. Final evaluation of safety and efficacy in the nasal and IV routes of midazolam drug during minor oral surgery was compared \[[Table 4](#T4){ref-type="table"}\].
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###### 

Ramsay sedation scale

  Score     Responsiveness
  ------- ---------------------------------------------------------------------------------------
  1       Patient is anxious and agitated or restless, or both
  2       Patient is cooperative, oriented, and tranquil
  3       Patient responds to commands only
  4       Patient exhibits brisk response to light glabellar tap or loud auditory stimulus
  5       Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus
  6       Patient exhibits no response

###### 

Cooperation score during the procedure

  --------------------------------------------------------------------------------------------------------
  Did the patient's movements during the local anesthesia or the procedure interfere or delay treatment?
   No interfering movements (0)
   Minor movements, positioning remained appropriate (1)
   Minor movements, patient had to be repositioned (2)
   Movements grossly interfered with the procedure (3)
  To what extent did the patient verbalize discomfort during the procedure?
   Not at all (0)
   Some verbalization, but did not indicate pain or discomfort (1)
   Some verbalization indicating pain or discomfort (2)
   Complained frequently during the procedure (3)
  Did the patient show nonverbal signs of discomfort during the procedure?
   Not at all (0)
   Slight discomfort, occasional grimaces (1)
   Moderate discomfort, feet/hands tensed, tears in eyes (2)
   cooperation score, sedation scoreMarked discomfort apparent during procedure (3)
  Sum of the numbers next to each response and record as the score of 0-9
  --------------------------------------------------------------------------------------------------------

###### 

Demographic data

            Male   Female   Total number of the patients   Age in mean (years)   Weight in mean (kg)
  --------- ------ -------- ------------------------------ --------------------- ---------------------
  Group A   23     07       30                             26.5                  51.8
  Group B   16     14       30                             31.2                  54.5

###### 

Diagnosis

                                               Group A   Group B
  -------------------------------------------- --------- ---------
  Impactions                                   23        24
  Periapical cysts                             1         3
  Fracture                                     2         1
  Implants                                     1         0
  Space infections                             1         1
  Nasal pack removal                           0         1
  Peripheral ossifying fibroma                 1         0
  Plate removal of postoperative trauma case   1         0
  Total number of patients                     30        30

###### 

Parameters---systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse rate (PR), oxygen saturation, respiratory rate (RR)

           SBP      DBP      PR      SPO~2~   RR                                      
  -------- -------- -------- ------- -------- ------- ------- ------- ------- ------- -------
  5 min    127.2    124      82.2    81       81.8    82.3    99.1    99.65   16.4    19
  10 min   126.9    121.8    82.1    80       82.6    82.2    99.2    98.95   17.15   17.65
  15 min   126      120.2    82      79.7     83.3    82.8    98.75   98.3    16.5    16.6
  20 min   125.1    120.05   82      79.05    83.4    82.84   98.32   98.2    15.84   16
  25 min   124.21   120      81.68   78.94    83.47   83.42   97.84   98.05   15.1    15.21
  30 min   124.10   119.94   81.57   78.73    82.94   83.57   97.84   97.95   15.65   14.68
  35 min   123.11   119.57   81.47   78.63    82.94   83.73   97.68   97.89   14.27   14.52
  40 min   122.23   119.78   81      78.52    83.22   83.73   97.84   97.61   15.31   14
  45 min   121.41   119.44   80.82   78.44    83.88   83.05   97.78   97.82   14.05   13.88
  50 min   120.47   119      81.05   78.77    84      83      97.83   97.82   13.83   14
  55 min   120.23   118.88   79.64   79.88    84.35   83.2    98.17   97.82   13.94   14.94
  60 min   120.11   118.88   79.41   78.33    84.94   83.16   98.56   97.9    14      15.17

###### 

Scores---cooperation score, sedation score

           Co-operation score   Sedation score          
  -------- -------------------- ---------------- ------ ------
  5 min    6.25                 6.5              2.2    2.55
  10 min   5.49                 5.45             3      2.8
  15 min   4.5                  4.6              3      2.75
  20 min   4.16                 4.23             3      3
  25 min   4.12                 4.09             3      3.21
  30 min   4.02                 4.08             3.05   3.21
  35 min   4.06                 3.9              3.21   3.32
  40 min   4.05                 3.8              3.28   3.16
  45 min   3.98                 4.1              3.06   3.11
  50 min   3.86                 3.85             3.12   2.94
  55 min   3.8                  3.79             3.12   3
  60 min   3.8                  3.75             3.06   3

P[ROCEDURE]{.smallcaps} {#sec1-3}
=======================

Preoperatively, on the day of surgery all the physiologic parameters such as heart rate, blood pressure, oxygen saturation, respiratory rate (RR), and anxiety scale were recorded. Prior to start of surgery, 0.1 mg/kg midazolam was administered either intranasally or intravenously. Intraoperatively, all patients were monitored for every 5 min till the end of procedure (15--60 min) for the following parameters: blood pressure, RR, pulse, oxygen saturation, sedation ratings by Ramsay sedation scale\[[@ref2]\] \[[Table 1](#T1){ref-type="table"}\], and patient's cooperation score\[[@ref3]\] \[[Table 2](#T2){ref-type="table"}\] were recorded \[[Table 6](#T6){ref-type="table"}\]. Patient verbal response was deter mined by talking to the patient intermittently.

Postoperatively, the following questions were asked after 30 min of recovery to determine the postoperative sedation effects in each patient.

Do you experience nausea/vomiting? Yes/No.Feeling sleepy? Yes/No.Had a headache: Yes/No.Feeling dizzy? Yes/No.Other aches/pain? Yes/No.Dreams? Yes/No.Hiccups? Yes/No.

After 1 hour of the procedure, patients were asked whether they were able to recollect the procedure to assess the retrograde and anterograde amnesia. Postoperative anxiety was assessed in all the patients using anxiety scale \[[Table 9](#T9){ref-type="table"}\]. Patients were discharged with an escort when they were able to walk steadily \[[Table 8](#T8){ref-type="table"}\].

###### 

Anxiety score

  Test or control                                                     Mean    *N*   Std. deviation
  ----------------------------- -------- ---------------------------- ------- ----- ----------------
  Intravenous                   Pair 1   Preoperative anxiety score   11.70   20    2.055
  Postoperative anxiety score   6.95     20                           1.605         
  Nasal                         Pair 1   Preoperative anxiety score   12.65   20    2.777
  Postoperative anxiety score   6.20     20                           1.508         

###### 

Postoperative sedation

            Postoperative sedation   
  --------- ------------------------ ---
  Group A   95                       5
  Group B   95                       5

###### 

Amnesia

            Anterograde   Retrograde        
  --------- ------------- ------------ ---- ----
  Group A   100           0            10   90
  Group B   100           0            15   85

Statistical analysis and correlations were performed using statistical package for social sciences statistics analyzing software.

R[ESULTS]{.smallcaps} {#sec1-4}
=====================

The demographic data of the patients in group A are presented in [Table 3](#T3){ref-type="table"}. The average age was 26.5 years, of which 23 male and 7 female patients included under group A with a mean weight of 51.8 kg. The demographic data of the patients in group B are presented in [Table 3](#T3){ref-type="table"}. The average age was 31.2 years, including 16 male and 14 female patients under group B with a mean weight of 54.5 kg.

D[ISCUSSION]{.smallcaps} {#sec1-5}
========================

Conscious sedation is a method of depression of the central nervous system, which allows the operator to perform a surgical procedure during which the patient retains protective reflexes. In combination with local anesthesia, it is a safe alternative to general anesthesia for the control of perioperative pain and anxiety in outpatient surgery.\[[@ref4]\] It is useful in those patients whose anxiety levels are more and who are unlikely to cooperate during minor oral surgical procedures, and can be induced by various routes of administration such as inhalation, intranasal (IN) spray, IV, oral, and intramuscular routes.\[[@ref5]\] In this study, patients were chosen for IN and IV routes of midazolam administration.

In this study, preoperative mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 129.6 and 82.7 mm of Hg, respectively in patients of group A. There was a decrease in both SBP and DBP by 7 mm of Hg and 3 mm of Hg, respectively during intraoperative period from 5th to 60th minute. Preoperative mean SBP and DBP were 127.5 and 80.7 mm of Hg, respectively in patients of group B and there was a decrease in both SBP and DBP of about 5 mm of Hg and 2 mm of Hg, respectively during intraoperative period from 5th to 60th minute \[[Table 5](#T5){ref-type="table"}\].

Gilchrist *et al*.\[[@ref7]\] assessed the use of IN midazolam (0.25 mg/kg) in pediatric dental patients requiring extractions or simple surgical procedures who may otherwise have required a general anesthetic and concluded that those physiological parameters remained stable. Gupta *et al*.\[[@ref9]\] observed that higher dosage of midazolam (0.06 mg/kg) produced better quality of anxiolysis and sedation with lesser rates of intraoperative recall without significantly affecting the heart rate, RR, and SBP as compared to a lower dose (0.02 mg/kg). However, higher dose (0.06 mg/kg) causes a significant fall in DBP and oxygen saturation in room air. Watanabe *et al*.\[[@ref10]\] observed cardiovascular depression after midazolam administration, and the degree of depression depended on the plasma concentration. When used at higher doses (ranging from 0.2 to 0.3 mg/kg) midazolam has been shown to decrease SBP and DBP, and mean arterial pressure.

Therefore, this study shows that the SBP and DBP decreased when midazolam was administrated either as IV or as an IN spray in all patients within the physiological limits.

In this study, in the IN group the average pulse rate preoperatively was 83 beats/min (bmp), and there was an increase in the average pulse from 5th minute (81.8 bpm) to 60th minute (84.94 bpm) intraoperatively. In IV group, the average pulse rate preoperatively was 83.5 bpm, and there was an increase in the average pulse rate from 5th minute (82.3 bpm) to 60th minute (83.16 bpm) intraoperatively.

In the literature review study by AlSarheed,\[[@ref6]\] various IN sedatives used to achieve conscious sedation during dental procedures amongst children were compared and concluded that IN midazolam was effective for modifying behavior in mild to moderately anxious children; however, for more invasive or prolonged procedures, stronger sedatives are recommended. Similarly Shashikiran *et al*.\[[@ref12]\] undertook a study to evaluate midazolam as a pediatric conscious sedative agent for a routine Indian dental setup and to compare its efficacy and safety when administered by IN and intramuscular routes, at a dosage of 0.2 mg/kg body weight, and stated that there was slight increase in pulse rate in the IN group but that was not significant. Blumer *et al*.\[[@ref13]\] in their study examined if changes in oxygen saturation and pulse rate of pediatric patients during conscious sedation with midazolam and nitrous oxide are associated with child's behavior and concluded that poor behavior of pediatric patients does not affect oxygen saturation, but it increases the pulse rate of children under sedation with midazolam and nitrous oxide. Similarly, P. Van Der Bijl *et al*.\[[@ref25]\] compared intravenously administered midazolam (0.1 mg/kg) with placebo in a randomized study in 50 patients undergoing oral surgical procedures under local anesthesia and stated that there is no increase in pulse rate in both the groups. In this study, in both groups, all patients showed an increase in pulse rate irrespective of the route of administration of midazolam drug.

This study showed that in IN group, there was an average preoperative SPO~2~ of 98.45%. The SPO~2~ percentage at 5th minute was 99.1% and by 60th minute it was 98.56% intraoperatively. In IV group, there was an average preoperative SPO~2~ of 99.1%. The average SPO~2~ percentage at 5th minute was 99.65% and by 60th minute it was 97.9% intraoperatively. If midazolam is given rapidly, it may produce apnea. In doses used for induction (0.2 mg/kg) of anesthesia, it causes respiratory depression, but in this study the dosage used was 0.1 mg/kg, which is less than the dosage in induction anesthesia and none of the patients showed desaturation.\[[@ref15]\]

Lloyd *et al*.\[[@ref15]\] stated that there was no instance of oxygen desaturation below 94%. In a study by Rodrigo *et al*.,\[[@ref8]\] it was stated that the mean oxygen saturation during both procedures was 98% and the range was 97%--100%. Rodrigo *et al*.\[[@ref16]\] evaluated oxygen desaturation during third molar surgery under conscious sedation with midazolam and stated that there was no significant desaturation attributable to midazolam sedation. During the entire time up to the postoperative period, the oxygen saturation values were maintained and this observation is not different in both groups similar to the previous studies reported.

Lobb *et al*.\[[@ref11]\] showed the characteristics of midazolam and fentanyl when each was administered first for moderate IV sedation in a dental clinic. When fentanyl was administered before midazolam, there was a significant reduction in sedative/hypnotic dosages. However, when midazolam was administered first, there may have been a reduction in administration time and procedural recollection by the patient. From these findings, practitioners may want to consider midazolam-first sedation when patients are experiencing high anxiety or high gag reflex, whereas the use of fentanyl-first sedation may be recommended when a strong stimulus or painful procedures are required. Moreover, when a lighter level of sedation is desired to provide comfort, a lower-dose fentanyl administration first may enable a (pharmacodynamic) reduction in the amount of midazolam required compared with a midazolam-only sedation.\[[@ref14]\]

In this study, there was an average preoperative RR of 18.55 cycles/min in the IN group. The average RR at 5th minute was 19 cycles/min and at 60th minute was 15.17 cycles/min intraoperatively. Postoperatively average RR was 17.6 cycles/min. In IV group, the average RR preoperatively was 17.2 cycles/min. The average RR at 5th minute was 16.4 cycles/min and at 60th minute was 14 cycles/min intraoperatively. Postoperatively, the average RR reported was 15.5 cycles/min. Midazolam\[[@ref17]\] produces some respiratory depression in healthy humans. Midazolam with a dose of 0.15 mg/kg significantly reduces the ventilator response to CO~2~ and significantly reduces the mouth occlusion-pressure response to CO~2~, but in this study the dosage used was 0.1 mg/kg, and there was no significant decrease in the respiration rate.\[[@ref18]\]

Lloyd *et al*.\[[@ref15]\] reported that there were no instances of respiratory depression. In the study by Shashikiran *et al*.,\[[@ref12]\] slight decrease in the RR in IN group was stated, but that was not significant clinically. Different studies showed varying results corresponding to RR after administration of midazolam intravenously.

This study showed that in IN group the average preoperative anxiety score was 12.65 and postoperative anxiety score was 6.20. In the IV group, the average preoperative score was 11.70 and postoperative score was 6.95. Burstein *et al*.\[[@ref18]\] evaluated midazolam following IN administration to adult dental surgery patients and ascertained the effect of midazolam on anxiety. Anxiety was evaluated using a 100-mm visual analogue scale and they stated that there was a reduction in anxiety score \[[Table 7](#T7){ref-type="table"}\]. Hollenhors *et al*.\[[@ref19]\] evaluated the effectiveness of intranasally administered midazolam spray in preventing claustrophobic responses of patients undergoing magnetic resonance (MR) imaging and concluded that a sizeable reduction in MR imaging--related anxiety and improved MR image quality were seen with patients who received IN midazolam spray. Gilchrist *et al*.\[[@ref7]\] assessed the use of IN midazolam (0.25 mg/kg) and was found that it provided adequate anxiolysis for majority of the children. This study shows that there was significant decrease in anxiety score from preoperative to postoperative period in both the groups significantly in correlation with the previous studies.

The study showed complete anterograde amnesia in both the groups. Retrograde amnesia in IV group was seen in 15% and in intranasal group, it was seen in 10% of the patients. Luyk *et al*.\[[@ref20]\] compared the amnesic properties and psychomotor recovery between a bolus injection of midazolam and a bolus injection followed by continuous infusion of midazolam in patients for third molar surgery and stated that the patients experienced significant amnesia to local anesthetic injection in both groups. Kupietzky *et al*.\[[@ref21]\] compared anterograde amnesic effects of midazolam with hydroxyzine in children undergoing dental treatment with those drugs plus nitrous oxide, using a recall test and concluded that midazolam was more effective in creating amnesia than hydroxyzine.

This study shows that the patient cooperation was increased by midazolam in both routes of drug administration with patients who gave minimal movements during procedure, positioning of the patient remained appropriate, some verbalization, but it did not indicate pain or discomfort and occasional grimaces. Similarly Walbergh *et al*.\[[@ref22]\] stated that most of the children were slightly drowsy when brought into the operatory and some of them were euphoric and smiling when midazolam was given intravenously. Lloyd *et al*.\[[@ref15]\] used IN midazolam as an alternative to general anesthesia in the management of children with oral and maxillofacial trauma and stated that children were cooperative during the procedure. This study shows that there is an increase in patient's cooperation levels after administrating the midazolam either intravenously or intranasally, in all the patients.

This study shows that the sedation score increased in both the groups after administration of midazolam from 5th minute to 60th minute. In both the groups, onset of action ranged between 5 and 10 min and in IN group the onset of action was faster when compared to IV group, and the patients responded to verbal commands throughout the procedure. Rose *et al*.\[[@ref23]\] evaluated 90 children sedated with IN midazolam and they were moderately drowsy but usually did not fall completely asleep. The average time to peak plasma concentrations and maximal effect is 10 min. Walbergh *et al*.\[[@ref22]\] stated that IN midazolam shows a rapid onset of 10--15 min and a short duration of effect (40--60 min). Bünz and Gossle\[[@ref24]\] confirmed the bioavailability of midazolam via the nasal route in 38 children prior to ear, nose, and throat surgery. Their results revealed that by giving a dose of 0.2 mg/kg intranasally, the level of premeditation was sufficient in 79% of the patients 5 min after application. Within 10 min, 95% of the children showed sufficient premedication. Lloyd *et al*.\[[@ref15]\] used IN midazolam as an alternative to general anesthesia in the management of children with oral and maxillofacial trauma and stated that children were cooperative or with good to excellent sedation with a dose of 0.2 mg/kg.

In this study, postoperatively all the patients in both groups were assessed for postoperative sedation effects and recovery. All the patients recovered from effects of sedation to full alertness and were able to walk steadily within 1 h after the surgery. One patient in the IN group complained of hiccups in the recovery phase, which subsided within half an hour and one patient in IV group complained about drowsiness during recovery phase, which lasted for 45 min. Overall recovery of patients was satisfactory in both groups irrespective of the route of administration.

Our study was a generalized study with a wide range of minor oral surgical procedures majorly in adults. The average duration of the procedure ranged between 20 and 60 min, which cannot be compared with other studies as the other studies were either carried out only on a single surgical procedure in adults or in routine dental treatments in children.

Midazolam administered either intravenously or intranasally did not produce much difference in anxiety, patient cooperation, and sedation, and all the physiological parameters were maintained under normal range. The sedation and anxiolysis observed in patients with IN route of administration were better when compared to the IV route. Hence, the choice of administration of drug is based on the willingness of patient as the IV route demands needle puncture. In this study, it was proved that IN route of administration had better convenience and compliance of patient with the reduced chance of infection and over sedation caused through IV route, in addition to other advantages such as rapid onset of action and rapid absorption when given intranasally.

C[ONCLUSION]{.smallcaps} {#sec1-6}
========================

It can be concluded that IN midazolam was not inferior to the conventional IV drug both in attaining conscious sedation and the recovery while maintaining the physiological parameters. It may also be said that IN spray has all the advantages of IV midazolam without the disadvantages of pain, fear, and infections associated with IV injections and also bypasses the portal circulation, increasing the bioavailability of drug absorbed through richly vascular nasal mucosa. More number of surgical procedures and large patients sample size are required for further research studies.
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